Literature DB >> 16901022

A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence.

Enkhe Badamgarav, Lorraine A Fitzpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16901022     DOI： 10.4065/81.8.1009

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  13 in total

1.  Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers.

Authors:  Maura D Iversen; Ruchita R Vora; Amber Servi; Daniel H Solomon
Journal:  J Geriatr Phys Ther       Date:  2011 Apr-Jun       Impact factor: 3.381

2.  [Osteoporosis treatment with biphosphonates: Approaches to care reality].

Authors:  Angel Vicente Molinero; Salvador Lou Arnal; Esteban Medina Orgaz; Sergio Muñoz Jacobo; José Antonio Ibáñez Estrella
Journal:  Aten Primaria       Date:  2010-06-11       Impact factor: 1.137

3.  Characteristics associated with bone mineral density responses to alendronate in men.

Authors:  Erik D Swenson; Karen E Hansen; Andrea N Jones; Zhanhai Li; Brooke Baltz-Ward; Arthur A Schuna; Mary E Elliott
Journal:  Calcif Tissue Int       Date:  2013-03-15       Impact factor: 4.333

Review 4.  Denosumab: a review of its use in postmenopausal women with osteoporosis.

Authors:  Lesley J Scott
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

5.  Cost-effective osteoporosis treatment thresholds: the United States perspective.

Authors:  A N A Tosteson; L J Melton; B Dawson-Hughes; S Baim; M J Favus; S Khosla; R L Lindsay
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

6.  Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.

Authors:  Robert A Yood; Kathleen M Mazor; Susan E Andrade; Srinivas Emani; Wing Chan; Kristijan H Kahler
Journal:  J Gen Intern Med       Date:  2008-09-12       Impact factor: 5.128

7.  Adherence to alendronate in male veterans.

Authors:  K E Hansen; E D Swenson; B Baltz; A A Schuna; A N Jones; M E Elliott
Journal:  Osteoporos Int       Date:  2007-09-26       Impact factor: 4.507

8.  Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).

Authors:  C Cooper; F Jakob; C Chinn; E Martin-Mola; P Fardellone; S Adami; N C Thalassinos; J Melo-Gomes; D Torgerson; A Gibson; F Marin
Journal:  Osteoporos Int       Date:  2007-10-30       Impact factor: 4.507

Review 9.  Compliance and persistence with osteoporosis therapies.

Authors:  Stuart L Silverman; Deborah T Gold
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

10.  Treatment of postmenopausal osteoporosis, patient perspectives - focus on once yearly zoledronic acid.

Authors:  Raj Carmona; Rick Adachi
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.